Major technical and pharmacological advances mean that lung transplantation (LTx) now
offers a realistic opportunity for long-term survival in selected patients with endstage …

Lung transplantation (LTx) has traditionally been limited by a lack of suitable donor lungs.
With the recognition that lungs are more robust than initially thought, the size of the donor …

OBJECTIVES End-stage lung disease continues to rise despite the lack of suitable lung
donors, limiting the numbers of lung transplants performed each year. Expanded donor …

Transplantation is considered a valuable option in the treatment of end-stage lung disease.
However, organs from multi-organ donors available for transplantation are far fewer than the …

Lung transplantation can be a life-extending treatment for patients with end-stage respiratory
failure; however, despite continuous improvement in donor management, donor organ …

Context Many potential donor lungs deteriorate between the time of brain death and
evaluation for transplantation suitability, possibly because of the ventilatory strategy used …

Background In an era of increasing ex vivo lung perfusion (EVLP) use, it remains important
to describe what outcomes can be achieved without EVLP, by taking an aggressive …

Rationale: One of the limitations associated with lung transplantation is the lack of available
organs. Objective: To determine whether a lung donor–management protocol could …

Background Lung transplantation remains the only treatment for end-stage lung disease.
Availability of suitable lungs does not parallel this growing trend. Centers using donation …

Lung donor shortages have resulted in the critical appraisal of cadaveric donor acceptability
criteria and the gradual relaxation of once strict guidelines. Many centers have reported their …